ACE-031
Also known as: ACE031
An activin receptor decoy that blocks myostatin and related ligands to promote significant muscle growth. Studied for muscular dystrophy.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~10–14 days
Research dosing
Subcutaneous injection
Mechanism of Action
Soluble ActRIIB decoy receptor that sequesters myostatin, activin A, and GDF-11, removing multiple negative regulators of muscle mass.
Key Research Areas
Frequently Asked Questions
What is ACE-031?▾
How does ACE-031 work?▾
What is the recommended dosage for ACE-031?▾
What is the half-life of ACE-031?▾
Is ACE-031 FDA approved?▾
Ready to get started with ACE-031?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about ACE-031 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.